Search research articles
Contact Us
Filters
Showing results (81-90 of 142) with videos related to
Page
of 15
Sort By:
Archives of Internal Medicine
|
July 25, 2007
Influence of a performance-improvement initiative on quality of care for patients hospitalized with heart failure: results of the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF)
Gregg C Fonarow, William T Abraham, Nancy M Albert, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
November 14, 2016
Sex differences in early dyspnea relief between men and women hospitalized for acute heart failure: insights from the RELAX-AHF study
Sven Meyer, John R Teerlink, Marco Metra, et al.
European Journal of Heart Failure
|
October 8, 2014
Diuretic response in patients with acute decompensated heart failure: characteristics and clinical outcome--an analysis from RELAX-AHF
Adriaan A Voors, Beth A Davison, John R Teerlink, et al.
Journal of the American College of Cardiology
|
April 26, 2008
Quality of care of and outcomes for African Americans hospitalized with heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure) registry
Clyde W Yancy, William T Abraham, Nancy M Albert, et al.
Journal of Cardiac Failure
|
November 10, 2016
Evaluating the Efficacy, Safety, and Tolerability of Serelaxin When Added to Standard Therapy in Asian Patients With Acute Heart Failure: Design and Rationale of RELAX-AHF-ASIA Trial
Naoki Sato, Carolyn S P Lam, John R Teerlink, et al.
European Journal of Heart Failure
|
December 12, 2024
End-organ protective effect of serelaxin in patients hospitalized for heart failure: Results of the biomarker substudy of Relaxin in Acute Heart Failure-2 (RELAX-AHF-2)
Adriaan A Voors, Marco Metra, Douwe Postmus, et al.
Journal of the American College of Cardiology
|
January 30, 2007
Highlights of the Year in JACC 2006
Anthony N DeMaria, Ori Ben-Yehuda, Gregory K Feld, et al.
American Heart Journal
|
July 24, 2007
Influence of diabetes on characteristics and outcomes in patients hospitalized with heart failure: a report from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)
Barry H Greenberg, William T Abraham, Nancy M Albert, et al.
JACC. Heart Failure
|
December 3, 2014
Safety and tolerability of omecamtiv mecarbil during exercise in patients with ischemic cardiomyopathy and angina
Barry H Greenberg, Willis Chou, Khalil G Saikali, et al.
Journal of the American College of Cardiology
|
January 24, 2009
Highlights of the Year in JACC 2008
Anthony N DeMaria, Ori Ben-Yehuda, Jeroen J Bax, et al.
Page
of 15
Search research articles
Search
Showing results (81-90 of 142) with videos related to
Sort By:
Page
of 15
Archives of Internal Medicine
|
July 25, 2007
Influence of a performance-improvement initiative on quality of care for patients hospitalized with heart failure: results of the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure (OPTIMIZE-HF)
Gregg C Fonarow, William T Abraham, Nancy M Albert, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
November 14, 2016
Sex differences in early dyspnea relief between men and women hospitalized for acute heart failure: insights from the RELAX-AHF study
Sven Meyer, John R Teerlink, Marco Metra, et al.
European Journal of Heart Failure
|
October 8, 2014
Diuretic response in patients with acute decompensated heart failure: characteristics and clinical outcome--an analysis from RELAX-AHF
Adriaan A Voors, Beth A Davison, John R Teerlink, et al.
Journal of the American College of Cardiology
|
April 26, 2008
Quality of care of and outcomes for African Americans hospitalized with heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure) registry
Clyde W Yancy, William T Abraham, Nancy M Albert, et al.
Journal of Cardiac Failure
|
November 10, 2016
Evaluating the Efficacy, Safety, and Tolerability of Serelaxin When Added to Standard Therapy in Asian Patients With Acute Heart Failure: Design and Rationale of RELAX-AHF-ASIA Trial
Naoki Sato, Carolyn S P Lam, John R Teerlink, et al.
European Journal of Heart Failure
|
December 12, 2024
End-organ protective effect of serelaxin in patients hospitalized for heart failure: Results of the biomarker substudy of Relaxin in Acute Heart Failure-2 (RELAX-AHF-2)
Adriaan A Voors, Marco Metra, Douwe Postmus, et al.
Journal of the American College of Cardiology
|
January 30, 2007
Highlights of the Year in JACC 2006
Anthony N DeMaria, Ori Ben-Yehuda, Gregory K Feld, et al.
American Heart Journal
|
July 24, 2007
Influence of diabetes on characteristics and outcomes in patients hospitalized with heart failure: a report from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)
Barry H Greenberg, William T Abraham, Nancy M Albert, et al.
JACC. Heart Failure
|
December 3, 2014
Safety and tolerability of omecamtiv mecarbil during exercise in patients with ischemic cardiomyopathy and angina
Barry H Greenberg, Willis Chou, Khalil G Saikali, et al.
Journal of the American College of Cardiology
|
January 24, 2009
Highlights of the Year in JACC 2008
Anthony N DeMaria, Ori Ben-Yehuda, Jeroen J Bax, et al.
Page
of 15